| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BUDESONIDE | 205710 | 001 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.25MG/2ML | No | No | 2017/11/16 | 2017/11/16 | CIPLA | Prescription |
| BUDESONIDE | 205710 | 002 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.5MG/2ML | No | No | 2017/11/16 | 2017/11/16 | CIPLA | Prescription |
| BUDESONIDE | 205710 | 003 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 1MG/2ML | No | No | 2017/11/16 | 2017/11/16 | CIPLA | Prescription |
| BUDESONIDE | 205457 | 001 | ANDA | BUDESONIDE | TABLET, EXTENDED RELEASE;ORAL | 9MG | No | No | 2018/07/03 | 2018/07/03 | ACTAVIS LABS FL INC | Prescription |
| BUDESONIDE | 210897 | 001 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.5MG/2ML | No | No | 2018/11/09 | 2018/11/09 | LUPIN | Prescription |
| BUDESONIDE | 208851 | 001 | ANDA | BUDESONIDE | TABLET, EXTENDED RELEASE;ORAL | 9MG | No | No | 2020/09/17 | 2020/09/17 | MYLAN | Prescription |
| BUDESONIDE | 211922 | 001 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.25MG/2ML | No | No | 2021/04/14 | 2021/04/14 | SUN PHARM | Prescription |
| BUDESONIDE | 211922 | 002 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.5MG/2ML | No | No | 2021/04/14 | 2021/04/14 | SUN PHARM | Prescription |
| BUDESONIDE | 211922 | 003 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 1MG/2ML | No | No | 2021/04/14 | 2021/04/14 | SUN PHARM | Prescription |
| BUDESONIDE | 215328 | 001 | ANDA | BUDESONIDE | AEROSOL, FOAM;RECTAL | 2MG/ACTUATION | No | No | 2023/04/12 | 2023/04/12 | PADAGIS ISRAEL | Prescription |
| BUDESONIDE | 216667 | 001 | ANDA | BUDESONIDE | SUSPENSION;INHALATION | 0.5MG/2ML | No | No | 2023/11/29 | 2023/11/29 | EUGIA PHARMA | Prescription |